Company profile: Arrayit
1.1 - Company Overview
Company description
- Provider of proprietary life science technologies and consumables for disease prevention, treatment, and cure, including DNA microarrays for gene expression and genotyping, protein microarrays (antigens, antibodies, peptides), microarrayers (manufacturing robots), microarray software for controller, quantification, analysis, and design, microarray tools (pins, printheads, hybridization cassettes), and microarray scanners (colorimetric, CCD, sub-micron fluorescence).
Products and services
- DNA Microarrays: Arrayit engineers long‑oligonucleotide‑based DNA microarrays that enable gene expression profiling and genotyping across various organisms for research
- Protein Microarrays: Arrayit produces multi‑protein‑content protein microarrays containing antigens, antibodies, peptides, and other proteins for a wide range of protein research
- Microarray Scanners: Arrayit supplies sub‑micron‑fluorescence‑qualified microarray scanners, including colorimetric and CCD systems for scanning microarrays using colorimetric, CCD, and sub‑micron fluorescence
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Arrayit
Claritas Genomics
HQ: United States
Website
- Description: Provider of genomics solutions, established as a new venture through a partnership between Boston Children's Hospital and Life Technologies Corp.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Claritas Genomics company profile →
Swift Biosciences
HQ: United States
Website
- Description: Provider of molecular biology reagents for research and diagnostic applications; based in Ann Arbor, Michigan.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Swift Biosciences company profile →
Lifecode Health
HQ: United States
Website
- Description: Provider of patient-specific molecular information to improve patient lives, amid the growing accessibility of molecular tumor profiling and the challenge of analyzing and interpreting the expanding genomic and therapeutic data from next-generation sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lifecode Health company profile →
RoslinCT
HQ: United Kingdom
Website
- Description: Provider of cell therapy CDMO services, including cGMP clinical and commercial manufacturing; process and analytical development; iPSC cell line development and manufacture; and CRISPR-edited cell therapy product development. Offers expertise across cell types, genetic modification, cell expansion, and analytical testing (multi-color flow cytometry, ELISA, qPCR).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RoslinCT company profile →
Chromatin
HQ: United States
Website
- Description: Provider of plant breeding and genomics technologies for agricultural, energy, chemical, nutritional and pharmaceutical sectors. Develops sorghum for agriculture and renewable energy, and advances maize and wheat via high-yielding, disease- and climate-resilient traits. Services include genomic selection, high-throughput phenotyping, multi-trait analysis, environics for genotype prediction, and integrated genomics-phenomics modeling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chromatin company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Arrayit
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Arrayit
2.2 - Growth funds investing in similar companies to Arrayit
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Arrayit
4.2 - Public trading comparable groups for Arrayit
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →